BUFFONI, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 101
AS - Asia 98
EU - Europa 97
SA - Sud America 10
AF - Africa 3
Totale 309
Nazione #
US - Stati Uniti d'America 96
SG - Singapore 45
FI - Finlandia 36
IT - Italia 26
BD - Bangladesh 18
CN - Cina 15
GB - Regno Unito 9
BR - Brasile 8
DE - Germania 8
HK - Hong Kong 7
VN - Vietnam 5
CZ - Repubblica Ceca 3
IN - India 3
RU - Federazione Russa 3
CA - Canada 2
CH - Svizzera 2
ES - Italia 2
FR - Francia 2
JP - Giappone 2
TR - Turchia 2
TT - Trinidad e Tobago 2
AR - Argentina 1
AT - Austria 1
ET - Etiopia 1
HN - Honduras 1
ID - Indonesia 1
MK - Macedonia 1
NL - Olanda 1
PL - Polonia 1
SE - Svezia 1
SN - Senegal 1
UA - Ucraina 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 309
Città #
Helsinki 33
Singapore 22
Ashburn 18
San Jose 18
Hong Kong 7
Munich 7
New York 6
Beijing 5
Dallas 5
The Dalles 5
Los Angeles 4
Boardman 3
Milan 3
Mumbai 3
Orem 3
Poplar 3
Rome 3
Boston 2
Brno 2
Council Bluffs 2
Dalmine 2
Istanbul 2
Lappeenranta 2
London 2
Romola 2
Tokyo 2
Addis Ababa 1
Alagoinhas 1
Alcoy 1
Annapolis 1
Brescia 1
Buffalo 1
Cary 1
Chaguanas 1
Charlotte 1
Chicago 1
City of London 1
Colón 1
Conselheiro Lafaiete 1
Criciúma 1
Dakar 1
Dietikon 1
Gravesend 1
Ho Chi Minh City 1
Ivano-Frankivsk 1
Jaguaribe 1
Jakarta 1
Jinan 1
Johannesburg 1
Lauterbourg 1
Leipzig 1
Manaus 1
Manchester 1
Maracaibo 1
Mjölby 1
Moscow 1
Naples 1
Olomouc 1
Panama City 1
Phoenix 1
Piscataway 1
Redondo Beach 1
Salt Lake City 1
San Fernando 1
San Francisco 1
Sant'Anastasia 1
Santa Clara 1
Seattle 1
Shenzhen 1
Shijiazhuang 1
Sumaré 1
São João del Rei 1
São Paulo 1
Tegucigalpa 1
Thái Bình 1
Toronto 1
Turku 1
Vancouver 1
Vienna 1
Villa di Briano 1
Warsaw 1
Totale 221
Nome #
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 136
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 97
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 74
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study) 6
Totale 313
Categoria #
all - tutte 1.098
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.098


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20249 0 0 0 0 0 0 0 0 0 0 0 9
2024/202567 5 1 2 10 8 2 5 3 10 6 8 7
2025/2026233 8 13 10 26 19 24 43 14 12 21 33 10
2026/20274 4 0 0 0 0 0 0 0 0 0 0 0
Totale 313